Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research
Open Access
- 27 January 2023
- Vol. 15 (3), 784
- https://doi.org/10.3390/cancers15030784
Abstract
Phosphatidylinositol-3-kinase (PI3K) enzymes, producing signaling phosphoinositides at plasma and intracellular membranes, are key in intracellular signaling and vesicular trafficking pathways. PI3K is a family of eight enzymes divided into three classes with various functions in physiology and largely deregulated in cancer. Here, we will review the recent evidence obtained during the last 5 years on the roles of PI3K class I, II and III isoforms in tumor biology and on the anti-tumoral action of PI3K inhibitors in preclinical cancer models. The dependency of tumors to PI3K isoforms is dictated by both genetics and context (e.g., the microenvironment). The understanding of class II/III isoforms in cancer development and progression remains scarce. Nonetheless, the limited available data are consistent and reveal that there is an interdependency between the pathways controlled by all PI3K class members in their role to promote cancer cell proliferation, survival, growth, migration and metabolism. It is unknown whether this feature contributes to partial treatment failure with isoform-selective PI3K inhibitors. Hence, a better understanding of class II/III functions to efficiently inhibit their positive and negative interactions with class I PI3Ks is needed. This research will provide the proof-of-concept to develop combination treatment strategies targeting several PI3K isoforms simultaneously.Funding Information
- ANR JCJC program Radiance (Projet-ANR-18-CE14-0013)
- MSCA-ITN/ETN PhD-PI3K (675392)
- IUCT-O/ICR translational program
- Ligue Régionale contre le Cancer
- Fondation ARC (PJA2021060003932)
- ANR
- Laboratoire d’Excellence
This publication has 148 references indexed in Scilit:
- RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase IsoformsCell, 2013
- Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasisProceedings of the National Academy of Sciences of the United States of America, 2012
- Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressorBiochemical Journal, 2012
- Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver functionProceedings of the National Academy of Sciences of the United States of America, 2012
- Class III PI-3-kinase activates phospholipase D in an amino acid–sensing mTORC1 pathwayThe Journal of cell biology, 2011
- Pik3c3 deletion in pyramidal neurons results in loss of synapses, extensive gliosis and progressive neurodegenerationNeuroscience, 2011
- Activity of any class IA PI3K isoform can sustain cell proliferation and survivalProceedings of the National Academy of Sciences of the United States of America, 2010
- The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γProceedings of the National Academy of Sciences of the United States of America, 2008
- Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesisNature, 2007
- Phosphoinositide 3-Kinase C2β Regulates Cytoskeletal Organization and Cell Migration via Rac-dependent MechanismsMolecular Biology of the Cell, 2006